RHOA and neoplasm: Meanwhile, as a potential inhibitor of RhoA, EGCG may also inhibit the recruitment and persistent education of CAFs in breast cancer by blocking the RhoA/Rho-associated kinase (ROCK) signaling pathway, thus suppressing the invasion of tumor cells (127, 128).